Cargando…
Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
Use of non-vitamin K antagonist oral anticoagulants is spreading in the real world. Despite that, a strong need for antidotes/reversal agents is still reported by several physicians. Idarucizumab is a humanized monoclonal antibody fragment that binds specifically to dabigatran. Idarucizumab was appr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110633/ https://www.ncbi.nlm.nih.gov/pubmed/30174430 http://dx.doi.org/10.2147/TCRM.S140377 |